Lynn Csontos (she/her)
Stemcell Technologies Inc
Lynn Csontos has worked in the biotech industry for over 25 years transitioning from Chemical/Process Development and Manufacturing into Quality Assurance and Regulatory Affairs approximately halfway through her career.
Companies she has worked for include Biomira, QLT and now STEMCELL Technologies. Although her background is primarily with small molecule API and drug products, she has been able to leverage her knowledge of the regulations surrounding small molecules, peptides and lipids to navigate the regulatory landscape that is currently being defined for cell, gene and tissue engineered therapies.
Working at STEMCELL Technologies since 2008 she has had the opportunity to witness first-hand the ever-changing compliance requirements as they relate to regenerative medicine and is excited to be a part of such a diverse organization that is helping shape the future landscape of this emerging field.